Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
85.35
+2.63 (3.18%)
Aug 4, 2026, 9:57 AM EDT - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.25 billion as of August 4, 2026. Its market cap has increased by 300.47% in one year.
Market Cap
1.25B
Enterprise Value
1.23B
1-Year Change
300.47%
Ranking
Category
Stock Price
$85.35
ChartMarket Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.25B, an increase of 531.66%. That is a compound annual growth rate of 132.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.25B | 8.98% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.30B |
| Avalyn Pharma | 1.26B |
| Immatics | 1.23B |
| Ardelyx | 1.23B |
| Aktis Oncology | 1.23B |
| LB Pharmaceuticals | 1.23B |
| Novavax | 1.22B |
| MannKind | 1.21B |